Kestrel Group Ltd

What they do

Kestrel operates two principal activities: a Program Services business that earns fee revenue, and a Legacy Reinsurance segment that is in run-off, including AmTrust Reinsurance legacy business and other reinsurance portfolios acquired from Maiden. The company also holds a legacy alternative investment portfolio that it intends to sell down, and it describes itself as a capital light, fee-based insurance platform that may selectively deploy underwriting capacity through carrier partners or reinsurance. Maiden and Kestrel LLC are wholly owned subsidiaries of Kestrel Group Ltd, which began trading on Nasdaq under 'KG' on May 28, 2025.

Revenue drivers

• Program Services fee revenue — Fee income earned from the program services platform. Fee revenue was $3.7 million in Q2 2026 and $6.9 million for the six months ended June 30, 2026, versus $0.5 million and $1.4 million in the comparable 2025 periods.
• Legacy Reinsurance net premiums earned — Premiums from reinsurance portfolios in run-off, including AmTrust Reinsurance legacy business. Net premiums earned were $3.5 million in Q2 2026 and $6.6 million for the six months ended June 30, 2026.
• Net investment income — Income from the investment portfolio supporting insurance and legacy operations. Net investment income was $2.5 million in Q2 2026 and $5.1 million for the six months ended June 30, 2026.
• Alternative investments — A legacy portfolio of equity securities, equity method investments and other investments valued at $218.6 million as of December 31, 2025, which the company is seeking to dispose of; results flow through net realized and unrealized investment gains and losses and interest in income of equity method investments.

Recent performance

For the three months ended June 30, 2026, Kestrel reported a net loss of $8.1 million, compared to net income of $69.9 million in the same period of 2025, when results included a $73.6 million gain on bargain purchase from the Combination; excluding that gain, the Q2 2025 net loss was $3.7 million. Fee revenue rose to $3.7 million in Q2 2026 from $0.5 million a year earlier, and net premiums earned rose to $3.5 million from $2.4 million, but the Legacy Reinsurance segment recorded a $1.3 million underwriting loss versus $5.8 million of underwriting income in Q2 2025. That swing was driven largely by $1.9 million of adverse prior year loss development in Q2 2026 versus $7.8 million of favorable development a year earlier, primarily within the AmTrust Reinsurance legacy business. Net investment income was $2.5 million in Q2 2026 versus $1.5 million in Q2 2025, while net realized and unrealized investment losses were $3.0 million. For the six months ended June 30, 2026, the net loss was $15.5 million on revenue of $6.9 million in fee revenue and $6.6 million in net premiums earned.

Strategy

Management's stated focus is growing the fee income component of the Program Services business to increase pre-tax income while managing the continuing run-off of the legacy Maiden alternative asset and reinsurance portfolios. The company says that reducing the alternative investment portfolio and increasing liquidity are critical to repositioning the balance sheet, that it has ceased making new commitments to alternative asset classes, and that it seeks appropriate opportunities to dispose of those assets. It may selectively deploy underwriting capacity through existing insurance carrier partners or other reinsurance mechanisms to accelerate Program Services growth. A stated leading priority is recognition of the deferred tax asset on the consolidated balance sheet, which would increase GAAP book value and is tied to utilizing significant net operating loss carryforwards. Management also says it continues to take measures to reduce expenses where appropriate.

Risks

• Debt service burden — Interest expense on debt inherited from Maiden totals $19.1 million annually, and the company states its current revenues are insufficient to offset fixed costs.
• Adverse loss development — The Legacy Reinsurance segment recorded $1.9 million of adverse prior year loss development in Q2 2026 versus $7.8 million of favorable development in Q2 2025, primarily in the AmTrust Reinsurance legacy business.
• Alternative investment and liquidity risk — Kestrel held $218.6 million in alternative investments as of December 31, 2025, and management says cash consideration and professional expenses from the Combination used substantial unrestricted liquidity, making the planned sell-down of these assets a priority with no assurance of timing or returns.
• Reliance on AmTrust relationship — The company flags that inability to maintain its strategic relationship with AmTrust could adversely affect its business.

Outlook

Management says it expects the alternative investment portfolio to be reduced in future periods to reposition the balance sheet and increase liquidity, and that it does not expect to make new commitments to alternative investments at this time. The company states it believes revenue will continue to grow to a level sufficient to ultimately produce an operating profit, but that this may take several periods. Kestrel also says the run-off of legacy insurance liabilities may be more volatile than anticipated and that there is no assurance the run-off will proceed at levels needed to achieve its goals, noting that prior to the Combination Maiden entered into a Loss Portfolio Transfer and Adverse Development Cover Agreement with Cavello Bay Reinsurance Limited.